Search research articles
Contact Us
Filters
Showing results (661-670 of 687) with videos related to
Page
of 69
Sort By:
International Journal of Radiation Biology
|
February 4, 2021
Bringing together scientific disciplines for collaborative undertakings: a vision for advancing the adverse outcome pathway framework
Vinita Chauhan, Ruth C Wilkins, Danielle Beaton, et al.
Journal of Environmental Management
|
October 2, 2018
How practitioners integrate decision triggers with existing metrics in conservation monitoring
Claire N Foster, Luke S O'Loughlin, Chloe F Sato, et al.
Plos One
|
April 19, 2014
The trajectory of dispersal research in conservation biology. Systematic review
Don A Driscoll, Sam C Banks, Philip S Barton, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2009
Improving the developability profile of pyrrolidine progesterone receptor partial agonists
Lara S Kallander, David G Washburn, Tram H Hoang, et al.
AIDS (London, England)
|
January 1, 1996
Ethnic differences in women with HIV infection in Britain and Ireland. The study group for the mrc collaborative study of HIV infection in women
J Anderson, R Melville, D J Jeffries, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 14, 2021
Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients
M P Dent, E Vaillancourt, R S Thomas, et al.
Vaccine
|
July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial
, R R Abu-Elyazeed, T Heineman, et al.
Bioorganic & Medicinal Chemistry
|
February 3, 2024
Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement
Linda S Barton, James F Callahan, Juan Cantizani, et al.
Journal of Medicinal Chemistry
|
December 6, 1996
Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists
J M Samanen, F E Ali, L S Barton, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
Nils Krone, Nicole Reisch, Jan Idkowiak, et al.
Page
of 69
Search research articles
Search
Showing results (661-670 of 687) with videos related to
Sort By:
Page
of 69
International Journal of Radiation Biology
|
February 4, 2021
Bringing together scientific disciplines for collaborative undertakings: a vision for advancing the adverse outcome pathway framework
Vinita Chauhan, Ruth C Wilkins, Danielle Beaton, et al.
Journal of Environmental Management
|
October 2, 2018
How practitioners integrate decision triggers with existing metrics in conservation monitoring
Claire N Foster, Luke S O'Loughlin, Chloe F Sato, et al.
Plos One
|
April 19, 2014
The trajectory of dispersal research in conservation biology. Systematic review
Don A Driscoll, Sam C Banks, Philip S Barton, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 21, 2009
Improving the developability profile of pyrrolidine progesterone receptor partial agonists
Lara S Kallander, David G Washburn, Tram H Hoang, et al.
AIDS (London, England)
|
January 1, 1996
Ethnic differences in women with HIV infection in Britain and Ireland. The study group for the mrc collaborative study of HIV infection in women
J Anderson, R Melville, D J Jeffries, et al.
Regulatory Toxicology and Pharmacology : RTP
|
August 14, 2021
Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients
M P Dent, E Vaillancourt, R S Thomas, et al.
Vaccine
|
July 16, 2013
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial
, R R Abu-Elyazeed, T Heineman, et al.
Bioorganic & Medicinal Chemistry
|
February 3, 2024
Exploration of the P1 residue in 3CL protease inhibitors leading to the discovery of a 2-tetrahydrofuran P1 replacement
Linda S Barton, James F Callahan, Juan Cantizani, et al.
Journal of Medicinal Chemistry
|
December 6, 1996
Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists
J M Samanen, F E Ali, L S Barton, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
Nils Krone, Nicole Reisch, Jan Idkowiak, et al.
Page
of 69